The American College of Surgeons’ National Surgical Quality Improvement Program (ACS NSQIP) has recognized Crouse Hospital as one of 26 ACS NSQIP participating hospitals in the United States that have achieved exemplary outcomes for surgical patient care.
As a participant in NSQIP, Crouse tracks the outcomes of inpatient surgical procedures and collects data that directs patient safety and the quality of surgical care improvements. The hospital then benchmarks its data against more than 300 other participating hospitals and health systems.
The NSQIP recognition program commends a select group of hospitals for achieving exemplary outcome performances related to patient management in five clinical areas: DVT (deep vein thrombosis, thrombophlebitis and pulmonary embolism); cardiac incidents (cardiac arrest and myocardial infarction); pneumonia; SSI (surgical site infections-superficial and deep incisional and organ-space SSIs); and urinary tract infection. Crouse attained exemplary outcomes in the following areas: cardiac complications; surgical site infections; unplanned intubation; morbidity and use of ventilators. Risk-adjusted data from the June 2010 ACS NSQIP Semiannual Report were used to determine which hospitals demonstrated exemplary outcomes.
“This recognition from the American College of Surgeons affirms Crouse Hospital’s commitment to patient safety and quality surgical care,” said Crouse President and CEO Paul Kronenberg, MD. “This distinction tells patients that they are receiving high-quality surgical care, which is reflective of the outstanding team of surgeons, nurses and technicians who provide surgical services here at Crouse.”
NSQIP is the only nationally validated quality improvement program that measures and enhances the care of surgical patients. The program measures the actual surgical results 30 days postoperatively as well as risk adjusts patient characteristics to compensate for differences among patient populations and acuity levels.
The goal of ACS NSQIP is to reduce surgical morbidity (infection or illness related to a surgical procedure) and surgical mortality (death related to a surgical procedure) and to provide a firm foundation for surgeons to apply what is known as the “best scientific evidence” to the practice of surgery. Additionally, when adverse effects from surgical procedures are reduced and/or eliminated, a reduction in healthcare costs follows. NSQIP is currently used in over 300 hospitals across the country.